Logo image of COVH.PA

COVIVIO HOTELS SACA (COVH.PA) Stock Fundamental Analysis

Europe - EPA:COVH - FR0000060303 - REIT

24.3 EUR
-0.6 (-2.41%)
Last: 9/12/2025, 7:00:00 PM
Fundamental Rating

4

Overall COVH gets a fundamental rating of 4 out of 10. We evaluated COVH against 42 industry peers in the Diversified REITs industry. COVH has only an average score on both its financial health and profitability. COVH is quite expensive at the moment. It does show a decent growth rate.


Dividend Valuation Growth Profitability Health

5

1. Profitability

1.1 Basic Checks

COVH had positive earnings in the past year.
In the past year COVH had a positive cash flow from operations.
The reported net income has been mixed in the past 5 years: COVH reported negative net income in multiple years.
COVH had a positive operating cash flow in each of the past 5 years.
COVH.PA Yearly Net Income VS EBIT VS OCF VS FCFCOVH.PA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 200M -200M 400M

1.2 Ratios

The Return On Assets of COVH (2.89%) is comparable to the rest of the industry.
COVH has a Return On Equity of 5.88%. This is in the better half of the industry: COVH outperforms 64.29% of its industry peers.
COVH's Return On Invested Capital of 3.68% is fine compared to the rest of the industry. COVH outperforms 61.90% of its industry peers.
Measured over the past 3 years, the Average Return On Invested Capital for COVH is in line with the industry average of 3.38%.
Industry RankSector Rank
ROA 2.89%
ROE 5.88%
ROIC 3.68%
ROA(3y)3.26%
ROA(5y)1.11%
ROE(3y)6.53%
ROE(5y)1.93%
ROIC(3y)3.85%
ROIC(5y)2.91%
COVH.PA Yearly ROA, ROE, ROICCOVH.PA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 5 -5 10 -10

1.3 Margins

COVH has a Profit Margin of 78.96%. This is amongst the best in the industry. COVH outperforms 85.71% of its industry peers.
COVH's Profit Margin has declined in the last couple of years.
With an excellent Operating Margin value of 101.55%, COVH belongs to the best of the industry, outperforming 100.00% of the companies in the same industry.
In the last couple of years the Operating Margin of COVH has remained more or less at the same level.
Industry RankSector Rank
OM 101.55%
PM (TTM) 78.96%
GM N/A
OM growth 3Y10.91%
OM growth 5Y0%
PM growth 3Y43.44%
PM growth 5Y-10.66%
GM growth 3YN/A
GM growth 5YN/A
COVH.PA Yearly Profit, Operating, Gross MarginsCOVH.PA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 100 -100 -200

4

2. Health

2.1 Basic Checks

COVH has a Return on Invested Capital (ROIC), which is below the Cost of Capital (WACC), which means it is destroying value.
Compared to 1 year ago, COVH has about the same amount of shares outstanding.
The number of shares outstanding for COVH has been increased compared to 5 years ago.
Compared to 1 year ago, COVH has a worse debt to assets ratio.
COVH.PA Yearly Shares OutstandingCOVH.PA Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M
COVH.PA Yearly Total Debt VS Total AssetsCOVH.PA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2B 4B 6B

2.2 Solvency

COVH has an Altman-Z score of 1.06. This is a bad value and indicates that COVH is not financially healthy and even has some risk of bankruptcy.
COVH has a Altman-Z score of 1.06. This is in the better half of the industry: COVH outperforms 66.67% of its industry peers.
COVH has a debt to FCF ratio of 12.72. This is a negative value and a sign of low solvency as COVH would need 12.72 years to pay back of all of its debts.
COVH's Debt to FCF ratio of 12.72 is in line compared to the rest of the industry. COVH outperforms 52.38% of its industry peers.
A Debt/Equity ratio of 0.70 indicates that COVH is somewhat dependend on debt financing.
The Debt to Equity ratio of COVH (0.70) is comparable to the rest of the industry.
Industry RankSector Rank
Debt/Equity 0.7
Debt/FCF 12.72
Altman-Z 1.06
ROIC/WACC0.69
WACC5.31%
COVH.PA Yearly LT Debt VS Equity VS FCFCOVH.PA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 1B 2B 3B

2.3 Liquidity

COVH has a Current Ratio of 1.16. This is a normal value and indicates that COVH is financially healthy and should not expect problems in meeting its short term obligations.
Looking at the Current ratio, with a value of 1.16, COVH belongs to the top of the industry, outperforming 85.71% of the companies in the same industry.
A Quick Ratio of 1.16 indicates that COVH should not have too much problems paying its short term obligations.
COVH has a Quick ratio of 1.16. This is amongst the best in the industry. COVH outperforms 85.71% of its industry peers.
Industry RankSector Rank
Current Ratio 1.16
Quick Ratio 1.16
COVH.PA Yearly Current Assets VS Current LiabilitesCOVH.PA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M

4

3. Growth

3.1 Past

COVH shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 241.67%, which is quite impressive.
The earnings per share for COVH have been decreasing by -12.16% on average. This is quite bad
COVH shows a decrease in Revenue. In the last year, the revenue decreased by -5.26%.
COVH shows a small growth in Revenue. Measured over the last years, the Revenue has been growing by 2.29% yearly.
EPS 1Y (TTM)241.67%
EPS 3Y62.03%
EPS 5Y-12.16%
EPS Q2Q%-15.59%
Revenue 1Y (TTM)-5.26%
Revenue growth 3Y14.81%
Revenue growth 5Y2.29%
Sales Q2Q%-12.96%

3.2 Future

The Earnings Per Share is expected to grow by 0.90% on average over the next years.
Based on estimates for the next years, COVH will show a small growth in Revenue. The Revenue will grow by 0.55% on average per year.
EPS Next Y3.01%
EPS Next 2Y0.9%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year-1.19%
Revenue Next 2Y0.55%
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
COVH.PA Yearly Revenue VS EstimatesCOVH.PA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 50M 100M 150M 200M 250M
COVH.PA Yearly EPS VS EstimatesCOVH.PA Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2023 2024 2025 2026 0.5 1 1.5

2

4. Valuation

4.1 Price/Earnings Ratio

With a Price/Earnings ratio of 17.61, COVH is valued on the expensive side.
COVH's Price/Earnings ratio is in line with the industry average.
The average S&P500 Price/Earnings ratio is at 27.30. COVH is valued slightly cheaper when compared to this.
The Price/Forward Earnings ratio is 14.10, which indicates a correct valuation of COVH.
Compared to the rest of the industry, the Price/Forward Earnings ratio of COVH indicates a slightly more expensive valuation: COVH is more expensive than 66.67% of the companies listed in the same industry.
The average S&P500 Price/Forward Earnings ratio is at 22.73. COVH is valued slightly cheaper when compared to this.
Industry RankSector Rank
PE 17.61
Fwd PE 14.1
COVH.PA Price Earnings VS Forward Price EarningsCOVH.PA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30

4.2 Price Multiples

The rest of the industry has a similar Enterprise Value to EBITDA ratio as COVH.
61.90% of the companies in the same industry are cheaper than COVH, based on the Price/Free Cash Flow ratio.
Industry RankSector Rank
P/FCF 16.6
EV/EBITDA 17.5
COVH.PA Per share dataCOVH.PA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 5 10 15 20

4.3 Compensation for Growth

The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates COVH does not grow enough to justify the current Price/Earnings ratio.
PEG (NY)5.85
PEG (5Y)N/A
EPS Next 2Y0.9%
EPS Next 3YN/A

6

5. Dividend

5.1 Amount

With a Yearly Dividend Yield of 6.02%, COVH is a good candidate for dividend investing.
Compared to an average industry Dividend Yield of 5.44, COVH pays a bit more dividend than its industry peers.
COVH's Dividend Yield is rather good when compared to the S&P500 average which is at 2.41.
Industry RankSector Rank
Dividend Yield 6.02%

5.2 History

The dividend of COVH decreases each year by -3.01%.
Dividend Growth(5Y)-3.01%
Div Incr Years4
Div Non Decr Years4
COVH.PA Yearly Dividends per shareCOVH.PA Yearly Dividends per shareYearly Dividends per share 2019 2020 2021 2022 2023 2024 2025 1 2 3

5.3 Sustainability

COVH pays out 19.16% of its income as dividend. This is a sustainable payout ratio.
DP19.16%
EPS Next 2Y0.9%
EPS Next 3YN/A
COVH.PA Yearly Income VS Free CF VS DividendCOVH.PA Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 200M -200M 400M
COVH.PA Dividend Payout.COVH.PA Dividend Payout, showing the Payout Ratio.COVH.PA Dividend Payout.PayoutRetained Earnings

COVIVIO HOTELS SACA

EPA:COVH (9/12/2025, 7:00:00 PM)

24.3

-0.6 (-2.41%)

Chartmill FA Rating
GICS SectorReal Estate
GICS IndustryGroupEquity Real Estate Investment Trusts (REITs)
GICS IndustryDiversified REITs
Earnings (Last)07-16 2025-07-16
Earnings (Next)10-22 2025-10-22
Inst Owners31.29%
Inst Owner ChangeN/A
Ins Owners0%
Ins Owner ChangeN/A
Market Cap3.84B
Analysts82.86
Price Target18.67 (-23.17%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 6.02%
Yearly Dividend1.3
Dividend Growth(5Y)-3.01%
DP19.16%
Div Incr Years4
Div Non Decr Years4
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)0%
Valuation
Industry RankSector Rank
PE 17.61
Fwd PE 14.1
P/S 14.73
P/FCF 16.6
P/OCF 10.5
P/B 1.1
P/tB 1.21
EV/EBITDA 17.5
EPS(TTM)1.38
EY5.68%
EPS(NY)1.72
Fwd EY7.09%
FCF(TTM)1.46
FCFY6.02%
OCF(TTM)2.31
OCFY9.52%
SpS1.65
BVpS22.14
TBVpS20.08
PEG (NY)5.85
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 2.89%
ROE 5.88%
ROCE 4.15%
ROIC 3.68%
ROICexc 4.07%
ROICexgc 4.31%
OM 101.55%
PM (TTM) 78.96%
GM N/A
FCFM 88.74%
ROA(3y)3.26%
ROA(5y)1.11%
ROE(3y)6.53%
ROE(5y)1.93%
ROIC(3y)3.85%
ROIC(5y)2.91%
ROICexc(3y)4.03%
ROICexc(5y)3.03%
ROICexgc(3y)4.17%
ROICexgc(5y)3.12%
ROCE(3y)4.35%
ROCE(5y)3.29%
ROICexcg growth 3Y33.75%
ROICexcg growth 5Y5.13%
ROICexc growth 3Y32.01%
ROICexc growth 5Y4.39%
OM growth 3Y10.91%
OM growth 5Y0%
PM growth 3Y43.44%
PM growth 5Y-10.66%
GM growth 3YN/A
GM growth 5YN/A
F-Score5
Asset Turnover0.04
Health
Industry RankSector Rank
Debt/Equity 0.7
Debt/FCF 12.72
Debt/EBITDA 6.97
Cap/Depr 152.56%
Cap/Sales 51.52%
Interest Coverage 4.11
Cash Conversion 103.65%
Profit Quality 112.39%
Current Ratio 1.16
Quick Ratio 1.16
Altman-Z 1.06
F-Score5
WACC5.31%
ROIC/WACC0.69
Cap/Depr(3y)165.18%
Cap/Depr(5y)147.82%
Cap/Sales(3y)30.61%
Cap/Sales(5y)33.22%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)241.67%
EPS 3Y62.03%
EPS 5Y-12.16%
EPS Q2Q%-15.59%
EPS Next Y3.01%
EPS Next 2Y0.9%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-5.26%
Revenue growth 3Y14.81%
Revenue growth 5Y2.29%
Sales Q2Q%-12.96%
Revenue Next Year-1.19%
Revenue Next 2Y0.55%
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-8.53%
EBIT growth 3Y27.34%
EBIT growth 5Y2.29%
EBIT Next Year-17.92%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-7.29%
FCF growth 3Y35.97%
FCF growth 5Y2.55%
OCF growth 1Y24.43%
OCF growth 3Y30.01%
OCF growth 5Y4.76%